A randomized controlled trial of 5-day regimen of azithromycin and a 10-day regimen of co-amoxiclav for treatment of acute sinusitis

Iranian Journal of Clinical Infectious Diseases

Volumn 5, Issue 3, 2010, Pages 137-141

  Lari, Abdolaziz Rastegar ^a   Ghaffariyeh, Alireza ^b   Etesam, Noushi ^c   Mostafavi, Hamid ^c   Alaghehbandan, Reza ^d  

^a IRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b Kosar Hospital   (Iran)

^c Exir Pharmaceutical Company   (Iran)

^d MEMORIAL UNIVERSITY OF NEWFOUNDLAND   (Canada)

Author keywords

Acute sinusitis; Azithromycin; Co amoxiclav

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; AZITHROMYCIN; UNCLASSIFIED DRUG; ZIMEXIR;

ACUTE SINUSITIS; ARTICLE; CONTROLLED STUDY; DOSAGE SCHEDULE COMPARISON; DRUG COST; DRUG EFFICACY; DRUG RESPONSE; DRUG TOLERABILITY; HUMAN; MAJOR CLINICAL STUDY; PATIENT COMPLIANCE; RANDOMIZED CONTROLLED TRIAL; REMISSION; SEX DIFFERENCE; SINGLE BLIND PROCEDURE; SINGLE DRUG DOSE; TREATMENT DURATION; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT;

EID: 84857082330     PISSN: 17355109     EISSN: 20081081     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Sharp HJ, Denman D, Puumala S, Leopold DA. Treatment of acute and chronic rhinosinusitis in the United States, 1999-2002. Arch Otolaryngol Head Neck Surg. 2007;133:260-65.
2. Merenstein D, Whittaker C, Chadwell T, Wegner B, D'Amico F. Are antibiotics beneficial for patients with sinusitis complaints? A randomized double-blind clinical trial. J Fam Pract. 2005;54:144-51.
3. Williamson IG, Rumsby K, Benge S, Moore M, Smith PW, Cross M, et al. Antibiotics and topical nasal steroid for treatment of acute maxillary sinusitis: a randomized controlled trial. JAMA. 2007;298:2487-96.
4. Young J, De Sutter A, Merenstein D, van Essen GA, Kaiser L, Varonen H, et al. Antibiotics for adults with clinically diagnosed acute rhinosinusitis: a meta-analysis of individual patient data. Lancet. 2008;371:908-14.
5. Bucher HC, Tschudi P, Young J, Périat P, Welge- Lüussen A, Züst H, et al. Effect of amoxicillinclavulanate in clinically diagnosed acute rhinosinusitis: a placebo-controlled, double-blind, randomized trial in general practice. Arch Intern Med. 2003;163:1793-98.
6. Dolor RJ, Witsell DL, Hellkamp AS, Williams JW, Califf RM, Simel DL. Comparison of cefuroxime with or without intranasal fluticasone for the treatment of rhinosinusitis. The CAFFS Trial: a randomized controlled trial. JAMA. 2001;286:3097-105.
7. Goetzel RZ, Hawkins K, Ozminkowski RJ. The health and productivity cost burden of the "top 10" physical and mental health conditions affecting six large U.S. employers in 1999. J Occup Environ Med. 2003;45:5-14.
8. Meltzer EO, Hamilos DL, Hadley JA, Lanza DC, Marple BF, Nicklas RA. Rhinosinusitis: developing guidance for clinical trials. Otolaryngol Head Neck Surg. 2006;135(5 suppl):S31-S80.
9. US Food and Drug Administration, Guidance for industry. Acute bacterial sinusitis: developing drugs for treatment Available at: http://www.fda.gov/CDER/GUIDANCE/3895dft.htm (Accessed July 27, 2010).
10. Williams JW, Aguilar C, Cornell J. Antibiotics for acute maxillary sinusitis. Cochrane Database Syst Rev 1999;3:CD000243.
11. Marple BF, Roberts CS, de Caprariis PJ, Reisman AB. Onset of symptom resolution in adults with acute bacterial rhinosinusitis treated with a single dose of azithromycin extended release compared with 10 days of levofloxacin: a retrospective analysis of a randomized, double-blind, double-dummy trial. Clin Ther. 2007;29:2690-98.
12. Murray JJ, Emparanza P, Lesinskas E, Tawadrous M, Breen JD. Efficacy and safety of a novel, single-dose azithromycin microsphere formulation versus 10 days of levofloxacin for the treatment of acute bacterial sinusitis in adults. Otolaryngol Head Neck Surg. 2005;133:194-200.
13. Marple BF, Roberts CS, Frytak JR, Schabert VF, Wegner JC, Bhattacharyya H, et al. Azithromycin extended release vs amoxicillin/clavulanate: symptom resolution in acute sinusitis. Am J Otolaryngol. 2010;31(1):1-8.